Cosette Pharmaceuticals, Inc. has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma ...

A paper published in The Lancet showed that four out of four young children with Leber congenital amaurosis 4 retinal dystrophy due to a genetic deficiency of Aryl-hydrocarbon-interacting protein-like ...

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver(I) ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement ...

Health researchers working with DENT Neurologic Institute, Jamaica pharmaceutical company to increase global clinical research.

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

Adjusted EPS of $0.92 topped estimates of $0.53. Revenue climbed to $747 million, beating the forecasted $712 million. Net ...